200 related articles for article (PubMed ID: 6303690)
1. Menses induction and second-trimester pregnancy termination using a polymeric controlled release vaginal delivery system containing (15S)15-methyl PGF2 alpha methyl ester.
Bygdeman M; Christenssen N; Gréen K; Vesterqvist O; Roseman TJ; Tuttle ME; Spilman CH
Contraception; 1983 Feb; 27(2):141-51. PubMed ID: 6303690
[TBL] [Abstract][Full Text] [Related]
2. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
Scher J; Jeng DY; Kerenyi TD
Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
[TBL] [Abstract][Full Text] [Related]
3. Menses induction in rhesus monkeys using a controlled-release vaginal delivery system containing (15S) 15-methyl prostaglandin F2 alpha methyl ester.
Spilman CH; Beuving DC; Forbes AD; Roseman TJ; Bennett RM; Biermacher JJ; Tuttle ME
Fertil Steril; 1984 Oct; 42(4):638-43. PubMed ID: 6489542
[TBL] [Abstract][Full Text] [Related]
4. Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl ester.
Roy S; Brenner PF; Marrs RP; Mishell DR
Contraception; 1980 Aug; 22(2):137-52. PubMed ID: 7449379
[TBL] [Abstract][Full Text] [Related]
5. The vaginal administration of 9-deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortion.
Ballard CA
Contraception; 1981 Aug; 24(2):151-7. PubMed ID: 7297067
[TBL] [Abstract][Full Text] [Related]
6. Termination of early gestation with (15S)-15-methyl prostaglandin F2 alpha methyl ester vaginal suppositories.
Marrs RP; Brenner PF; Roy S; Mishell DR
Contraception; 1981 Dec; 24(6):617-30. PubMed ID: 6173157
[TBL] [Abstract][Full Text] [Related]
7. Termination of second trimester pregnancy with a long-acting vaginal pessary containing 15-methyl-PGF2 alpha methyl ester.
Int J Gynaecol Obstet; 1983 Apr; 21(2):159-65. PubMed ID: 6136437
[TBL] [Abstract][Full Text] [Related]
8. Use of different prostaglandin analogues for terminating pregnancy at different terms.
Manuilova IA
Acta Med Hung; 1986; 43(2):133-8. PubMed ID: 3588156
[TBL] [Abstract][Full Text] [Related]
9. Induction of abortion by vaginal administration of 15(s)15-methyl prostaglandin F2alpha methyl ester. A comparison of two delivery systems.
Bygdeman M; Gréen K; Lundström V; Ramadan M; Fotiou S; Bergström S
Prostaglandins; 1976; 12 Suppl():27-51. PubMed ID: 968064
[TBL] [Abstract][Full Text] [Related]
10. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
[TBL] [Abstract][Full Text] [Related]
11. Termination of early pregnancy by a single-dose 3.0 mg 15-methyl PGF2alpha methyl ester vaginal suppository.
Mandelin M
Prostaglandins; 1978 Jul; 16(1):143-52. PubMed ID: 704921
[TBL] [Abstract][Full Text] [Related]
12. Termination of very early pregnancy by vaginal suppositories-(15S)-15-methyl prostaglandin F2 alpha methyl ester.
Wan LS; Stiber AJ; Turkel J
Contraception; 1981 Dec; 24(6):603-15. PubMed ID: 6173156
[TBL] [Abstract][Full Text] [Related]
13. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
Wagatsuma T; Tabuchi T; Tabei T; Kaku R
Contraception; 1979 Jun; 19(6):591-7. PubMed ID: 487809
[TBL] [Abstract][Full Text] [Related]
14. Vaginal administration of 15-methyl-PGF2 alpha methyl ester for preoperative cervical dilatation. Task force on prostaglandins for fertility regulation. The World Health Organization.
Contraception; 1981 Mar; 23(3):251-9. PubMed ID: 7016432
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of 15 (S) 15-methyl-PGF 2 alpha-methyl ester following vaginal administration for induction of abortion in women.
Bhaskar A; Dimov V; Baliga S; Kinra G; Hingorani V; Laumas KR
Contraception; 1979 Nov; 20(5):519-31. PubMed ID: 527343
[TBL] [Abstract][Full Text] [Related]
16. The effect of a 10 cm2, 0.5% 15-ME-PGF2alpha methyl ester intravaginal silastic device on abortion and plasma prostaglandin concentration.
Lauersen NH; Wilson KH
Prostaglandins; 1977 Apr; 13(4):755-62. PubMed ID: 857275
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of vaginal delivery systems containing 15[s]15-methyl PGF2alpha methyl ester.
Spilman CH; Beuving DC; Forbes AD; Roseman TJ; Larion LJ
Prostaglandins; 1976; 12 Suppl():1-16. PubMed ID: 968060
[TBL] [Abstract][Full Text] [Related]
18. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
el-Refaey H; Hinshaw K; Templeton A
Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
[TBL] [Abstract][Full Text] [Related]
19. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
Bygdeman M; Christensen N; Gréen K; Lundström V
Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
[TBL] [Abstract][Full Text] [Related]
20. First and midtrimester abortion with intramuscular injections of sulprostone.
Ballard CA
Contraception; 1981 Aug; 24(2):145-50. PubMed ID: 7297066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
